Early research (Phase 1)Ended earlyNCT03539484What this trial is testingRO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid TumorsWho this might be right forSolid Tumors Hoffmann-La Roche 26
Early research (Phase 1)Looking for participantsNCT06609187What this trial is testingGNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07730021What this trial is testingASP388B Given by Itself and With Standard Therapies in Participants With Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Astellas Pharma Global Development, Inc. 392
Testing effectiveness (Phase 2)Looking for participantsNCT07213817What this trial is testingAssess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid TumoursWho this might be right forLocally Advanced Solid TumorMetastatic Solid Tumor Ipsen 114
Early research (Phase 1)Study completedNCT04047862What this trial is testingStudy of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid TumorsWho this might be right forLocally Advanced and Metastatic Solid Tumors BeiGene 446
Early research (Phase 1)Study completedNCT01409343What this trial is testingTrasGEX™: Phase 1 Study in Cancer PatientsWho this might be right forSolid Tumors Glycotope GmbH 37
Testing effectiveness (Phase 2)Looking for participantsNCT07335497What this trial is testingCR-001 in Adult Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced / Metastatic Solid Tumors Crescent Biopharma, Inc. 290
Early research (Phase 1)Looking for participantsNCT05205109What this trial is testingAssess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Antengene Therapeutics Limited 98
Early research (Phase 1)Looking for participantsNCT07678970What this trial is testingSI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid TumorsWho this might be right forGastrointestinal TumorSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 10
Early research (Phase 1)Study completedNCT01273493What this trial is testingA Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic DysfunctionWho this might be right forNeoplasm MetastasesHepatic Insufficiency Janssen Research & Development, LLC 15
Early research (Phase 1)Active Not RecruitingNCT05907304What this trial is testingAssess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsWho this might be right forAdvanced or Metastatic Solid Tumors Erasca, Inc. 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289What this trial is testingCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more Rahul Aggarwal 83
Early research (Phase 1)UnknownNCT04128423What this trial is testingStudy of AMV564 in Subjects With Advanced Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Amphivena Therapeutics, Inc. 65
Early research (Phase 1)Not Yet RecruitingNCT06218940What this trial is testingHY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLCWho this might be right forNSCLC Stage IV Newsoara Biopharma Co., Ltd. 40
Early research (Phase 1)Looking for participantsNCT07607054What this trial is testingA First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.Who this might be right forLocally Advanced or Metastatic Solid Tumors Shanghai EpimAb Biotherapeutics Co., Ltd. 50
Early research (Phase 1)Study completedNCT01393509What this trial is testingThe First-in-human Phase I Trial of PU-H71 in Patients With Advanced MalignanciesWho this might be right forMetastatic Solid TumorLymphomaMyeloproliferative Neoplasms (MPN) Memorial Sloan Kettering Cancer Center 47
Early research (Phase 1)UnknownNCT05957471What this trial is testingStudy of BC3195 Monotherapy in Patients With Advanced Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Biocity Biopharmaceutics Co., Ltd. 27
Early research (Phase 1)Study completedNCT02410512What this trial is testingAssess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forNeoplasms Genentech, Inc. 610
Testing effectiveness (Phase 2)Ended earlyNCT03138889What this trial is testingBempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid TumorsWho this might be right forNon-Small Cell Lung Cancer Nektar Therapeutics 162
Early research (Phase 1)Study completedNCT02825940What this trial is testingAssess the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Administered Intravenously (IV) as a Single Agent or in Combination With Chemotherapy in Chinese Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forNeoplasms Hoffmann-La Roche 120